The Israeli Pharmaceutical Market is Valued at Just Under US$1.5 Billion in 2004, Equal to US$212 Per Capita

Research and Markets (researchandmarkets.com/reports/c8726) has announced the addition of Israel Outlook Pharmaceutical Country Intelligence Report 2004 to their offering.

(PRWEB) November 6, 2004 -- World Pharma Markets Outlook Reports are ideal for executives wanting to understand the key drivers in pharmaceutical markets worldwide. Each report provides a comprehensive analysis of the market and, importantly, provides 5-year market forecasts, national data projections, outlook and key developments such as regulation, pricing/reimbursement, health facilities and government policy. Importantly, the market can be seen in its global context with international market comparisons.

The Israeli pharmaceutical market is valued at just under US$1.5 billion in 2004, equal to US$212 per capita, the highest level in the Middle East, by some considerable margin. Market growth has been strong over the last decade, at around ten per cent per annum, despite the governments efforts to curtail pharmaceutical expenditure in more recent years.

The contents of this report are as follows:

1.Executive Summary

2.Pharmaceutical Market

3.Key National Data Projections

4.Sources

For more information visit http://www.researchandmarkets.com/reports/c8726

Laura Wood

Senior Manager

Research and Markets

press@researchandmarkets.com

Fax: +353 1 4100 980

###